Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Antizol approved in Canada for treatment of ethylene glycol poisoning

Dec. 6, 2000

Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS

Nov. 7, 2000

NIDA grant awarded to Nabi for nicotine vaccine research

Oct. 10, 2000

Alkermes completes patient enrollment in clinical trial of new treatment for alcoholism

Oct. 3, 2000

Stimulation of brain reward areas by nicotine causes addiction

Aug. 31, 2000

Trial reveals utility of acupuncture in treating cocaine dependence

Aug. 28, 2000

Serotonin antagonist improves drinking behavior in early-onset alcoholism

Aug. 24, 2000

Orphan Medical's Antizol sNDA accepted for filing

Aug. 22, 2000

Zyban may reduce weight gain in smoking cessation

Aug. 16, 2000

Methoxsalen shown to reduce smoking by increasing the bioavailability of nicotine

July 31, 2000

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...